INVESTMENT SECURITIES, RELATED PARTY (Tables)

12 Months Ended

Sep. 30, 2023

Investment Securities Related Party

Schedule of investment securities related party

Fair Value of Intellectual Property	$	1,500
Prepaid Expenses		65,661
Due from Employee		1,071
Note Receivable		64,400
Accrued Interest Receivable		23,989
Investment Securities		8,423,366
Convertible Note Receivable		10,000
Accounts Payable		1,269,041
Notes Payable		400,000
Accrued Expenses Related Parties		162,011
Notes Payable Related Party		5396
Accrued Expenses		203,037
Enterprise Value		10,563,930
Less: Total Debt		(2,038,343	)
Portion of Enterprise Value Attributable to Shareholders		8,525,587
Fair Value Per Share	$	0.186168

Schedule of comprehensive Income

470,588 Common Shares of Zander Therapeutics, Inc.
	Basis		Fair Value		Total Unrealized Gains		Net Unrealized Gain or (Loss) realized during the quarter ended September  30, 2023
$	5,741	$	87,608	$	81,867	$	0

725,000 Series M Preferred of Zander Therapeutics, Inc.
	Basis		Fair Value		Total Unrealized Gain		Net Unrealized Gain or (Loss) realized during the quarter  ended September 30, 2023
$	13,124	$	134,971	$	121,847	$	0